Search - tctmd.com

Displaying 81 - 100 of 177

Sort: Relevancy | Date

News Daily News

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

Todd Neale

September 23, 2020

News Industry News

Breakthrough Cardiac-Telemedicine™ device, now CE-Cleared.

September 15, 2020

News Daily News

Case by Case, a Portrait Emerges of COVID-19’s Cardiovascular Fingerprint

Caitlin E. Cox

June 15, 2020

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Caitlin E. Cox

May 08, 2020

News Opinion CV Team Dispatch

March 2020 News Roundup

L.A. McKeown

March 12, 2020

News Industry News

Thrombolex Bashir® Endovascular Catheter First-In-Human (FIH) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

March 05, 2020

News Daily News

Impella Redux: JAMA Publication Post-AHA Renews Push for More Data

Caitlin E. Cox

February 14, 2020

News Daily News

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Shelley Wood

January 24, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

Caitlin E. Cox

November 17, 2019

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Caitlin E. Cox

November 06, 2019

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

News Daily News

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Todd Neale

August 19, 2019

News Daily News

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

Marcus A. Banks

July 24, 2019

News Industry News

Medtronic HeartWare(TM) HVAD(TM) Implanted via Less Invasive Thoracotomy Shows 95 Percent Freedom from Disabling Stroke at Two Years

July 08, 2019

News Conference News HRS 2019

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

Todd Neale

May 15, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

Advertisement

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

Breakthrough Cardiac-Telemedicine™ device, now CE-Cleared.

Case by Case, a Portrait Emerges of COVID-19’s Cardiovascular Fingerprint

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

March 2020 News Roundup

Thrombolex Bashir® Endovascular Catheter First-In-Human (FIH) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

Impella Redux: JAMA Publication Post-AHA Renews Push for More Data

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

More Adverse Events, Higher Costs With Impella: New Observational Studies

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

Medtronic HeartWare(TM) HVAD(TM) Implanted via Less Invasive Thoracotomy Shows 95 Percent Freedom from Disabling Stroke at Two Years

BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content